An internationally recognized expert in breast cancer and other malignancies, Dr. Antman is best known for developing a standardized treatment regimen for sarcoma and mesothelioma. She has conducted groundbreaking clinical research in bone marrow transplantation using mobilization of peripheral blood-derived stem cells and effective supportive care.
Dr. Antman’s extensive clinical research experience has led her to become a strong advocate for public funding for research, facilitating entry into clinical trials, and approval of new therapies. Now an administrator at a major medical school, she continues to foster and collaborate on research, consult on patient care, and teach.
Career Highlights
2015-2017 Chair, Council of Deans, American Association of Medical Colleges
2011 Elected Member, Academy of Medicine
2008 Distinguished Service Award for Scientific Leadership, American Society of Clinical Oncology
2004-2005 Deputy Director for Translational and Clinical Sciences, National Cancer Institute
2003-2004 President, AACR
1998-2001 Board of Directors, AACR
1997 President, American Society for Blood and Marrow Transplantation
1997 Elected Fellow, American Association for the Advancement of Science
1996 Jeffrey A. Gottlieb Memorial Award, UT MD Anderson Cancer Center
1996-2003 Director, Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons
1995 President, ASCO
1993-2003 Chief, Division of Medical Oncology, Wu Professor of Medicine and Pharmacology, Columbia University College of Physicians and Surgeons
1986 Fellow, American College of Physicians
1977-2003 Instructor through associate professor, Harvard Medical School
1974 MD, Columbia University College of Physicians and Surgeons